How Much Additional Time Could Treatment Give My Dog?

14. How Much Additional Time Could Treatment Give My Dog?

When your dog has been diagnosed with cancer, one of the hardest questions to ask is, “How much more time could treatment give us?”

It is a deeply emotional question because you are not simply asking about weeks, months, or years. You are asking how much more time you may have to share ordinary mornings, favorite walks, quiet evenings, familiar routines, and the small moments that make your dog’s life meaningful.

Unfortunately, there is no single answer that applies to every dog. Cancer treatment may provide only a small amount of additional time in some cases and several years in others. For certain localized cancers, treatment may even be curative. For more aggressive or advanced cancers, treatment may be intended to slow the disease, ease symptoms, and provide more comfortable time together.

The most helpful estimate will come from a veterinary oncologist who has reviewed your dog’s exact cancer type, grade, stage, overall health, and treatment options.

Why Is There No Single Answer?

Cancer is not one disease. Different cancers behave very differently, even when they affect dogs of similar ages or breeds.

The amount of time treatment may provide depends on factors such as:

• The exact type of cancer

• Tumor grade

• Cancer stage

• Tumor size and location

• Whether the cancer has spread

• Whether the tumor can be completely removed

• The treatment chosen

• Your dog’s overall health

• Symptoms present at diagnosis

• How the cancer responds to treatment

• Whether complications develop

• Whether your dog can comfortably complete treatment

Two dogs with the same diagnosis may have very different experiences.

What Does “Additional Time” Really Mean?

When a veterinarian discusses additional time, it is important to understand what is being compared.

They may be comparing:

• Treatment with no cancer-directed treatment

• Surgery alone with surgery plus chemotherapy

• Standard treatment with palliative care

• One chemotherapy protocol with another

• Immediate treatment with active monitoring

For example, if dogs receiving surgery alone have a median survival time of four months and dogs receiving surgery plus chemotherapy have a median survival time of ten months, the apparent difference is about six months.

However, this does not mean every dog will receive exactly six additional months. Some dogs may receive less benefit, while others may live much longer than expected.

What Is Median Survival Time?

Veterinarians often use the term median survival time when discussing prognosis.

The median is the point at which half the dogs in a study were still alive and half had died.

If a study reports a median survival time of ten months:

• Some dogs lived less than ten months.

• Some lived around ten months.

• Some lived considerably longer.

A median is not an expiration date for your dog.

It is a guide based on groups of dogs, not a prediction of exactly what will happen in your home.

What Is Average Survival Time?

An average, also called a mean, is calculated by adding all survival times together and dividing by the number of dogs in the study.

A few dogs who live much longer than expected can raise the average. For this reason, veterinary cancer studies often report the median instead.

Ask whether a number refers to:

• Median survival

• Average survival

• One-year survival

• Two-year survival

• Progression-free survival

• Overall survival

Each of these measurements tells you something different.

What Is Progression-Free Survival?

Progression-free survival describes how long the cancer remains stable without noticeably growing or spreading.

Progression may include:

• Enlargement of the primary tumor

• Development of new tumors

• Spread to lymph nodes or distant organs

• Return of cancer after remission

• Worsening symptoms

Your dog may still live beyond the progression-free period while receiving another treatment or palliative care.

What Is Overall Survival?

Overall survival generally measures how long dogs lived from a specific starting point, such as:

• The date of diagnosis

• The date of surgery

• The beginning of chemotherapy

• The start of another treatment

Always ask when the survival measurement begins. Numbers measured from different starting points cannot be compared directly.

How Much Time Can Surgery Add?

Surgery may offer the greatest benefit when the cancer is localized and can be completely removed.

Depending on the diagnosis, surgery may:

• Cure the cancer

• Prevent or delay recurrence

• Relieve pain

• Stop bleeding

• Remove an obstruction

• Improve mobility or organ function

• Provide months or years of disease control

For some dogs, surgery may not greatly extend life but can still improve comfort.

For example, removing a painful tumor may allow your dog to walk, rest, eat, or enjoy family time more comfortably, even when the cancer may already have spread microscopically.

How Much Time Can Chemotherapy Add?

Chemotherapy may provide additional time by:

• Producing remission

• Shrinking visible cancer

• Slowing progression

• Delaying recurrence

• Treating microscopic cancer cells after surgery

• Reducing symptoms

The benefit depends greatly on the cancer.

Some cancers, such as certain lymphomas, may respond very well to chemotherapy and enter remission for many months. Other cancers respond less predictably, and treatment may provide only a modest increase in survival.

Ask your oncologist for information about the exact chemotherapy protocol recommended for your dog.

How Much Time Can Radiation Add?

Radiation therapy may provide months or years of local tumor control in selected cases.

It may be used to:

• Treat a tumor that cannot be completely removed

• Delay recurrence after surgery

• Shrink a mass

• Reduce pain

• Control bleeding

• Relieve pressure on nerves or organs

• Improve mobility

Palliative radiation may not greatly extend life but can sometimes make the time remaining much more comfortable.

Definitive radiation may offer longer control, but it usually requires more appointments and repeated anesthesia or sedation.

How Much Time Can Immunotherapy Add?

The potential benefit of immunotherapy depends on:

• The exact treatment

• The cancer type

• Whether visible cancer remains

• Whether it is combined with surgery, chemotherapy, or radiation

• The amount of research available

Some immunotherapies may delay recurrence or progression. Others remain experimental, and the expected benefit may be uncertain.

Ask whether there are published outcomes for dogs with the same diagnosis and stage as your dog.

Examples Of How Outcomes Can Differ

These examples are not predictions for your individual dog. They simply show how much outcomes can vary depending on the cancer.

Canine Osteosarcoma

For appendicular osteosarcoma, surgery alone or palliative radiation may provide a median survival time of approximately four to five months. Surgery followed by chemotherapy may increase median survival to approximately seven to twelve months.

For many families, the benefit of surgery also includes relief from severe bone pain, not only additional time.

Splenic Hemangiosarcoma

For splenic hemangiosarcoma, surgery alone is often associated with survival measured in a few months. Chemotherapy after surgery may add additional months for some dogs.

This can be especially difficult to hear. In these situations, the decision is often not only about how much time treatment may add, but whether that time is likely to be comfortable and meaningful.

Canine Lymphoma

Many dogs with multicentric lymphoma respond to chemotherapy and enter remission.

Remission may last for months, and some dogs live longer than expected. However, lymphoma commonly returns, and outcomes depend on the lymphoma subtype, treatment protocol, and how the dog responds.

Localized Low-Grade Tumors

Some localized, low-grade cancers that are completely removed may not significantly shorten a dog’s natural lifespan.

In these cases, treatment may provide years rather than months.

Why Might Published Numbers Not Match My Dog?

Cancer studies describe groups of dogs, but your dog is an individual.

The dogs in a study may differ in:

• Age

• Breed

• Cancer stage

• Tumor grade

• Overall health

• Previous treatment

• Treatment protocol

• Supportive care

• Follow-up testing

Some veterinary studies also include relatively small numbers of dogs, and treatments may have improved since the study was published.

Statistics can help guide decisions, but they cannot tell you exactly how much time your dog has.

Does Treatment Always Add Time?

No. Some dogs do not respond, and some may develop complications.

Treatment may provide little benefit when:

• The cancer is resistant

• The disease is very advanced

• Serious complications are already present

• The dog cannot tolerate treatment

• Treatment must be stopped

• The cancer progresses rapidly

• Another medical condition becomes more serious

Ask how many dogs receive little or no benefit, not only how long the dogs who responded lived.

Could Treatment Improve Comfort Without Adding Much Time?

Yes.

Treatment may still be worthwhile if it:

• Relieves pain

• Stops bleeding

• Restores appetite

• Improves breathing

• Shrinks an obstructive tumor

• Improves mobility

• Helps your dog sleep comfortably

• Restores interest in favorite activities

Sometimes the greatest benefit is not a longer life, but a better day.

A treatment that helps your dog feel more like themselves may be meaningful even when it does not greatly change the overall prognosis.

Could Treatment Add Time But Reduce Quality Of Life?

It is possible, although veterinary cancer treatment is generally designed to protect quality of life.

Possible burdens include:

• Repeated hospital visits

• Long travel

• Sedation or anesthesia

• Surgery and recovery

• Digestive side effects

• Fatigue

• Pain

• Infection risk

• Fear or anxiety

• Time away from home

Every dog responds differently.

Some dogs tolerate treatment remarkably well and continue eating, playing, and enjoying their normal routines. Others find the process more difficult.

Ask what most dogs experience and what would happen if your dog struggled with treatment.

How Should I Think About A Few Extra Weeks Or Months?

This is one of the most personal decisions a family may face.

When the expected benefit is limited, ask what that time may realistically look like.

Consider:

• Will my dog feel well during most of that time?

• How much time will be spent recovering?

• How often will we need to travel to appointments?

• Will my dog still enjoy food, walks, affection, and family time?

• Is pain likely to remain controlled?

• How likely is an emergency?

• Can treatment be stopped if it becomes too much?

A few comfortable months filled with connection, familiar routines, and joy may feel very meaningful.

At the same time, more time is not always better if most of it is spent feeling frightened, sick, or uncomfortable.

There is no universally correct choice.

Ask For The Best, Most Likely, And More Concerning Outcomes

Instead of asking for only one number, ask the oncologist to explain:

• The best reasonably possible outcome

• The most likely outcome

• The more concerning outcome

• The chance that treatment provides little benefit

• The percentage of dogs alive at six months

• The percentage alive at one year

• How soon you will know whether treatment is helping

This may give you a more realistic picture than a single median survival time.

Ask About Each Treatment Separately

When several options are available, ask for separate estimates for:

• Surgery alone

• Surgery plus chemotherapy

• Surgery plus radiation

• Chemotherapy alone

• Palliative radiation

• Comfort-focused care

This can help you understand how much each additional treatment may contribute.

Sometimes the difference is substantial. In other situations, an additional treatment may offer only a small or uncertain benefit.

Ask Whether The Statistics Truly Apply To Your Dog

The most useful survival estimates come from dogs with similar circumstances.

Ask whether the numbers are based on dogs with the same:

• Cancer type

• Grade

• Stage

• Tumor location

• Surgical margins

• Lymph-node status

• Treatment protocol

• Overall health

• Symptoms

A number that combines several stages or treatments may not accurately represent your dog’s situation.

How Will We Know Whether Treatment Is Helping?

Before beginning treatment, ask what success would look like.

It may mean:

• The tumor becomes smaller.

• The tumor remains stable.

• Lymph nodes return to normal size.

• Bloodwork improves.

• Pain decreases.

• Appetite returns.

• Energy improves.

• Breathing becomes easier.

• Your dog continues enjoying daily life.

Success does not always mean the cancer disappears.

Sometimes success means your dog feels well, remains comfortable, and continues doing the things they love.

Can We Try Treatment And Reassess?

In many situations, yes.

You may be able to begin treatment and reassess after:

• The first chemotherapy cycle

• A specific number of treatments

• Repeat imaging

• Recovery from surgery

• A short course of palliative radiation

• A trial of supportive medication

Treatment may be changed or stopped if:

• The cancer is not responding

• Side effects are too difficult

• Quality of life declines

• The burden becomes greater than the benefit

• Your family’s goals change

Ask in advance which parts of the plan are reversible and which are not.

Should I Choose Treatment For A Small Expected Benefit?

There is no single right answer.

A small potential benefit may feel worthwhile when:

• Your dog is currently comfortable and active.

• Treatment is expected to be well tolerated.

• The treatment may also relieve pain.

• The added time is likely to be good-quality time.

• Your family can manage the appointments and cost.

• Treatment does not remove future options.

It may feel less appropriate when:

• Your dog is already suffering.

• The chance of benefit is very low.

• Treatment is unlikely to improve comfort.

• Recovery may consume much of the expected time.

• Veterinary visits cause severe distress.

• Another serious illness already limits quality of life.

Choosing comfort-focused care is not giving up. It is choosing a different form of care centered on peace, relief, and dignity.

Questions To Ask The Veterinary Oncologist

• What is the expected survival without cancer-directed treatment?

• What is the expected survival with treatment?

• How much additional time might treatment realistically provide?

• Is that number a median, average, or range?

• Are the statistics based on dogs with the same stage and grade?

• What percentage of dogs respond?

• How many dogs receive little or no benefit?

• What quality of life do most dogs experience?

• Does treatment improve comfort as well as survival?

• How much time may be spent receiving or recovering from treatment?

• How soon will we know whether treatment is helping?

• Can treatment be adjusted or stopped?

• What would palliative care provide?

• What would you consider a successful outcome for my dog?

The Most Important Takeaway

Cancer treatment may provide a few additional weeks, several months, or many years. For some cancers, treatment may be curative. For others, the goal may be to slow the disease and provide more comfortable time.

The most important questions are not only:

• How much time might treatment add?

• How likely is my dog to receive that benefit?

• What will that time probably look like?

• Will my dog still feel like themselves?

• Will treatment protect comfort and joy?

Your dog is not a statistic.

No chart or study can measure the value of another tail wag, another peaceful nap beside you, or another day spent doing something your dog loves.

The goal is not simply to add more days. It is to protect the comfort, connection, and meaning within them.

References

Cornell University College of Veterinary Medicine. (n.d.-a). Cancer care at the Cornell University Hospital for Animals. Retrieved July 16, 2026, from https://www.vet.cornell.edu/departments-centers-and-institutes/sprecher-institute-comparative-cancer-research/cancer-care-cornell-university-hospital-animals

Cornell University College of Veterinary Medicine. (n.d.-b). Diagnosis and staging. Retrieved July 16, 2026, from https://www.vet.cornell.edu/departments-centers-and-institutes/sprecher-institute-comparative-cancer-research/treatment-strategies/diagnosis-and-staging

Cornell University College of Veterinary Medicine. (n.d.-c). Difficult decisions. Retrieved July 16, 2026, from https://www.vet.cornell.edu/departments-centers-and-institutes/riney-canine-health-center/canine-health-information/difficult-decisions

Cornell University College of Veterinary Medicine. (n.d.-d). Hemangiosarcoma in dogs. Retrieved July 16, 2026, from https://www.vet.cornell.edu/departments-centers-and-institutes/riney-canine-health-center/canine-health-information/hemangiosarcoma-dogs

Cornell University College of Veterinary Medicine. (n.d.-e). Oncology: Medical conditions. Retrieved July 16, 2026, from https://www.vet.cornell.edu/hospitals/services/oncology/oncology-medical-conditions

Cornell University College of Veterinary Medicine. (n.d.-f). Osteosarcoma in dogs. Retrieved July 16, 2026, from https://www.vet.cornell.edu/departments-centers-and-institutes/riney-canine-health-center/canine-health-topics/osteosarcoma-dogs

Cornell University College of Veterinary Medicine. (n.d.-g). Treatment strategies. Retrieved July 16, 2026, from https://www.vet.cornell.edu/departments-centers-and-institutes/sprecher-institute-comparative-cancer-research/treatment-strategies

Flory, A. B., Rassnick, K. M., Stokol, T., Scrivani, P. V., Erb, H. N., & Taeymans, O. (2011). Stage migration in dogs with lymphoma. Journal of Veterinary Internal Medicine, 25(5), 1187–1196. https://doi.org/10.1111/j.1939-1676.2011.0766.x

Marconato, L., Stefanello, D., Valenti, P., Bonfanti, U., Comazzi, S., Roccabianca, P., Caniatti, M., Romanelli, G., Massari, F., Zini, E., & Finotello, R. (2011). Predictors of long-term survival in dogs with high-grade multicentric lymphoma. Journal of the American Veterinary Medical Association, 238(4), 480–485. https://doi.org/10.2460/javma.238.4.480

Veterinary Cancer Society. (n.d.-a). Canine multicentric lymphoma. Retrieved July 16, 2026, from https://vetcancersociety.org/wp-content/uploads/2023/08/COMPLETE-Canine-Multicentric-Lymphoma.pdf

Veterinary Cancer Society. (n.d.-b). Chemotherapy FAQ. Retrieved July 16, 2026, from https://vetcancersociety.org/wp-content/uploads/2023/08/COMPLETE-Chemotherapy-FAQ.pdf

Veterinary Cancer Society. (n.d.-c). Clinical trials. Retrieved July 16, 2026, from https://vetcancersociety.org/resources/clinical-trials/